CLARCOR Announces Investment in BioProcess Technologies, Inc.
Norm Johnson, CLARCOR's Chairman and CEO, said: "We are very excited at the opportunity to invest in BPT, and particularly its proprietary waste water filtration technology. BPT manufactures industrial waste water treatment systems using a unique, patented filter media design based on a biological process to remove organic waste contaminants in industrial waste water streams. The process is a cost-effective solution applicable to industrial plants, residential developments, smaller municipalities as well as major waste water disposal and treatment facilities. BPT has sold its systems to major soft drink bottlers, manufacturers of foods and ingredients, agricultural concerns and for other organic waste water treatment applications.
"BPT's process works continuously unlike conventional systems that require a large footprint, high energy input and extended retention time to metabolize waste water. Importantly, it is a biological growth process based on a modular design that can be easily engineered to the required water flow treatment rate. We have successfully integrated BPT's technology with the waste water filtration systems that we currently sell in Europe and have seen significant improvements in filtration efficiencies.
"It is no secret that water is becoming an ever more scarce resource and that environmental concerns regarding water quality are increasing around the world. Our investment in BPT better positions CLARCOR to play an important role in a growing world-wide market."
Tim Burns, BPT's President said: "These are exciting times for BPT. BPT is a rapidly growing, profitable company and CLARCOR's capital and operational support will allow us to grow even faster. We have succeeded in selling our systems to large multi-national companies. With the additional resources from CLARCOR's investment in BPT, we expect to be even more successful in the future."
CLARCOR is based in Franklin, Tennessee, and is a diversified marketer and manufacturer of mobile, industrial and environmental filtration products and consumer and industrial packaging products sold in domestic and international markets. Common shares of the Company are traded on the New York Stock Exchange under the symbol CLC.
BioProcess Technologies is a privately-owned company based in Portsmouth, Rhode Island. Further information can be found at www.bioprocessh2o.com.
|Printer friendly Cite/link Email Feedback|
|Date:||May 2, 2008|
|Previous Article:||Fitch Downgrades 6 Classes from Toro ABS CDO II, Ltd./LLC.|
|Next Article:||Fitch Assigns San Francisco (California) Int'l Airport $427MM Rev Rfdg Bonds 'A'; Outlook Positive.|
|Fuji acquires BioProcess.|
|Handbook of Industrial Biocatalysis.|
|Handbook of food and bioprocess modeling techniques.|
|GE Healthcare to offer disposable equipment.|